FDA
-
-
-
-
-
-
-
ProPhase Labs (PRPH) Reports Prelim Positive Results for Equivir
-
-
-
-
-
-
-
ProPhase Labs Announces Plans to Initiate Clinical Trial of Equivir (OTC)
-
-
-
-
-
-
-
Impact BioMedical Announces License Agreement with ProPhase Labs to Produce and Distribute Viral-Fighting Compound Equivir
-
-
-
-
-
-
-
ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York
-
-
-
-
-
-
-
ProPhase Labs Schedules an Investor Conference Call for Tuesday, January 10th at 4:30 PM
-
322,238 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

